Replies to post #24117 on Can B Corp (CANB)

[sleekscape]

Hemp-derived THC products that fall into the category of Foods and Dietary Supplements are federally illegal

So are Hemp-derived CBD products that fall into these categories

Enforceability is a different discussion

Unfortunately, the drug exclusion clause in the FDCA has taken legal precedence over The 2018 Farm Bill — otherwise, we wouldn’t be in this current conundrum, would we?

There are enormous differences between CBD and THC in terms of risks to public safety and potential for abuse

MJ is a Schedule I Drug because of THC, not CBD

Most of the attorneys have gotten it wrong by focusing on the “different article” argument for Full Spectrum

Public safety is the reason why the FDA is going to be choosing the Pure CBD formulation

I personally have no issues whatsoever with THC in CBD products, and like many others, I would like to see it federally permitted in CBD Oil products under the following 2 conditions:

1) It is derived from Hemp (whose very definition includes cannabis containing THC at .3% or less on a dry weight basis)

2) The concentration of THC in CBD products is kept at .3% or below

However, it doesn’t really matter what I would like to see

I’m trying to figure out what the FDA is going to do, and even more importantly for me as an investor in the CBD Oil and CBD Beverage space, predict which specific composition of CBD products will be the first one to be given the FDA’s national blessing, because I foresee a massive herd of “CBD GREEN RUSH” investors flocking to those publicly traded companies which produce these first-ever no-strings-attached federally legal CBD products... and I want to stake out a position before they arrive

The following is not an exhaustive list, but here are a few of the reasons why the FDA isn’t a big fan of THC in CBD products:

THC is a Schedule I cannabinoid

THC is psychoactive

THC has abuse potential

THC impacts motor skills, i.e. driving

THC can negatively impact the brain and have harmful effects on cognition, memory, academic performance and mental health

For the above reasons, along with many others, the FDA views THC as a threat to public health and public safety

The NIH has also spent decades funding research on the “harms” of MJ and THC, so there is a tremendous amount of research out there on the negative effects of THC in comparison to the beneficial effects

THC is also the active pharmaceutical ingredient in several FDA-approved prescription medications — Marinol, Syndros, and Cesamet

The FDA is already being asked to make an exception to their guidelines (FDCA) by allowing one pharmaceutical drug, CBD, into dietary supplements and the food supply, and adding THC (particularly above .1%) alongside CBD is asking them to make a 2nd exception by allowing two different FDA-approved pharmaceutical medications into the same OTC products, with one of these exceptions being a Schedule I substance to boot


The evidence is already out there

Dr. Gottlieb has gone on record multiple times and you can watch the videos here:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153845048

Why do you think Mile High Labs and Canopy Growth have gone with Pure CBD for 2020?


Sleek

[Penny Masters]

So your saying CANB will not be the only FDA approved company to sell CBD pure isolate? ? Wow that will surprise some here that think some Dr. said it will be.